U.S. FDA issues VAI classification to Granules arm Virginia facility
Granules Pharmaceuticals Inc. File | Photo Credit: The Hindu The U.S. Food and Drug Administration (U.S. FDA) has issued an establishment inspection report (EIR) with a voluntary action indicated (VAI) classification to the Granules Pharmaceuticals Inc. (GPI) facility in Chantilly, Virginia. The regulator had inspected the facility from March 30 to April 3 and issued…
Read More “U.S. FDA issues VAI classification to Granules arm Virginia facility” »